Somatostatin Expressing (Som) Cortical Interneurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Somatostatin-expressing (SOM) interneurons are a major class of cortical GABAergic [neurons](/entities/neurons) that target dendritic shafts of pyramidal cells, providing feedforward and feedback inhibition[@jin1992]. They are critical for regulating cortical excitability and are significantly affected in neurodegenerative diseases[@palop2010]. [@palop2010]
Somatostatin Expressing (Som) Cortical Interneurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Somatostatin-expressing (SOM) interneurons are a major class of cortical GABAergic [neurons](/entities/neurons) that target dendritic shafts of pyramidal cells, providing feedforward and feedback inhibition[@jin1992]. They are critical for regulating cortical excitability and are significantly affected in neurodegenerative diseases[@palop2010]. [@palop2010]
Overview
Mermaid diagram (expand to render)
Somatostatin Cortical Interneurons are specialized neurons in the brain that play important roles in neurological function and are relevant to neurodegenerative diseases. These neurons are involved in critical processes such as neurotransmitter regulation, autonomic control, or sensory processing. [@rudy2011]
Dysfunction or degeneration of these neurons contributes to the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative disorders through effects on neurotransmitter systems, cellular metabolism, or neural circuit function. [@klausberger2008]
SOM interneurons are found throughout all layers of the cerebral [cortex](/brain-regions/cortex), with highest density in layers 2-4[@rudy2011]. Their axons primarily target the dendritic shafts of pyramidal cells, making them distinct from basket cells that target somata[@klausberger2008]. [@kubota1994]
Molecular Markers
Somatostatin (SST)
The defining feature is expression of somatostatin-14 and somatostatin-28, neuropeptides that inhibit neurotransmitter release[@jin1992]. [@wang2004]
NPY
Many SOM cells co-express neuropeptide Y[@kubota2011]. [@xu2013]
Calbindin
A subset expresses calbindin D-28k[@rudy2011]. [@silberberg2007]
Other Markers
GAD67: Essential for GABA synthesis[@klausberger2008]
nNOS: Some SOM cells co-express neuronal nitric oxide synthase[@kubota1994]
VIP-: Typically do not express vasoactive intestinal peptide[@rudy2011]
Subtypes
Martinotti Cells
The most common SOM subtype, with ascending axonal projections to layer 1 targeting pyramidal cell dendrites[@wang2004]. [@murayama2009]
Non-Martinotti SOM Cells
Found in deeper layers with different axonal targeting patterns[@xu2013]. [@davies1980]
Physiological Properties
Dendritic Targeting
Distal dendrites: Primary target of Martinotti cells[@wang2004]
IPSP timing: Delayed inhibition relative to somatic inhibition[@murayama2009]
Function in Neurodegeneration
Alzheimer's Disease
SOM interneurons are particularly vulnerable to [amyloid-beta](/proteins/amyloid-beta) toxicity[@palop2010]
Significant reduction in SOM neuron numbers observed in AD brains[@davies1980]
Somatostatin levels are decreased in AD, correlating with cognitive decline[@davies1981]
Their loss contributes to cortical hyperexcitability and network dysfunction[@busche2008]
May contribute to memory deficits through disinhibition[@rohn2001]
Parkinson's Disease
SOM neuron function altered in PD motor cortex[@day2006]
Their dendritic targeting may be affected by [alpha-synuclein](/mechanisms/alpha-synuclein) pathology[@braak2003]
Huntington's Disease
SOM interneurons relatively spared in HD[@cepeda2013]
May compensate for loss of other interneuron types[@cepeda2013]
Background
The study of Somatostatin Expressing (Som) Cortical Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@davies1981]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@busche2008]